Kestra Advisory Services, LLC Cara Therapeutics, Inc. Put Options Transaction History
Kestra Advisory Services, LLC
- $17.2 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CARA
# of Institutions
11Shares Held
885KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY745KShares$3.75 Million0.0% of portfolio
-
National Asset Management, Inc. Boca Raton, FL58.5KShares$294,6280.0% of portfolio
-
American Portfolios Advisors Holbrook, NY40.4KShares$203,7420.02% of portfolio
-
Rathbones Group PLC Liverpool, X020.2KShares$101,6260.0% of portfolio
-
Rothschild Investment Corp10.6KShares$53,4240.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $271M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...